Search Results - "Zhang, Leike"
-
1
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Published in Cell research (01-03-2020)Get full text
Journal Article -
2
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur
Published in Nature structural & molecular biology (01-06-2020)“…The antineoplastic drug carmofur is shown to inhibit the SARS-CoV-2 main protease (M pro ). Here, the X-ray crystal structure of M pro in complex with carmofur…”
Get full text
Journal Article -
3
Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives
Published in Nature communications (24-05-2021)“…The SARS-CoV-2 pandemic has triggered global efforts to develop therapeutics. The main protease of SARS-CoV-2 (M pro ), critical for viral replication, is a…”
Get full text
Journal Article -
4
Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
Published in Nature communications (15-06-2021)“…The ongoing pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) urgently needs an effective…”
Get full text
Journal Article -
5
Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin
Published in Nature structural & molecular biology (01-03-2021)“…The COVID-19 pandemic caused by nonstop infections of SARS-CoV-2 has continued to ravage many countries worldwide. Here we report that suramin, a 100-year-old…”
Get full text
Journal Article -
6
Screening of FDA-Approved Drugs for Inhibitors of Japanese Encephalitis Virus Infection
Published in Journal of virology (01-11-2017)“…Japanese encephalitis virus (JEV), an arthropod-borne flavivirus, is a major cause of acute viral encephalitis in humans. No approved drug is available for the…”
Get full text
Journal Article -
7
High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors
Published in Protein & cell (01-11-2021)“…A new coronavirus (SARS-CoV-2) has been identified as the etiologic agent for the COVID-19 outbreak. Currently, effective treatment options remain very limited…”
Get full text
Journal Article -
8
Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2
Published in Cell research (01-11-2021)Get full text
Journal Article -
9
Gallium maltolate has in vitro antiviral activity against SARS-CoV-2 and is a potential treatment for COVID-19
Published in Antiviral chemistry & chemotherapy (2020)“…Background Gallium has demonstrated strong anti-inflammatory activity in numerous animal studies, and has also demonstrated direct antiviral activity against…”
Get full text
Journal Article -
10
Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV‑2
Published in Journal of medicinal chemistry (24-02-2022)“…A novel series of peptidomimetic aldehydes was designed and synthesized to target 3C protease (3Cpro) of enterovirus 71 (EV71). Most of the compounds exhibited…”
Get full text
Journal Article -
11
Research on optimal operation of cascade pumping stations based on an improved sparrow search algorithm
Published in Water science and technology (15-10-2023)“…Abstract For the low efficiency and large loss of cascade pumping stations, aiming to maximize system efficiency, an optimized scheduling model of cascade…”
Get full text
Journal Article -
12
The metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatment
Published in Scientific reports (12-02-2015)“…Chronic infection caused by the hepatitis B virus (HBV), is strongly associated with hepatitis, fatty liver and hepatocellular carcinoma. To investigate the…”
Get full text
Journal Article -
13
Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
Published in Protein & cell (01-10-2020)“…Emerging and re-emerging RNA viruses occasionally cause epidemics and pandemics worldwide, such as the on-going outbreak of the novel coronavirus SARS-CoV-2…”
Get full text
Journal Article -
14
Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library
Published in Journal of virology (15-08-2018)“…Currently, there is no approved therapy to treat Lassa fever; therefore, repurposing of approved drugs will accelerate the development of a therapeutic…”
Get full text
Journal Article -
15
Structure-based development and preclinical evaluation of the SARS-CoV-2 3C-like protease inhibitor simnotrelvir
Published in Nature communications (13-10-2023)“…The persistent pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants…”
Get full text
Journal Article -
16
Ebola virus VP35 hijacks the PKA-CREB1 pathway for replication and pathogenesis by AKIP1 association
Published in Nature communications (26-04-2022)“…Ebola virus (EBOV), one of the deadliest viruses, is the cause of fatal Ebola virus disease (EVD). The underlying mechanism of viral replication and…”
Get full text
Journal Article -
17
A parallel multi-objective optimization based on adaptive surrogate model for combined operation of multiple hydraulic facilities in water diversion project
Published in Journal of hydroinformatics (01-06-2024)“…ABSTRACT In a complex pressurized water diversion project (WDP), the combined optimal operation of multiple hydraulic facilities is computationally expensive…”
Get full text
Journal Article -
18
Structure-based discovery of dual pathway inhibitors for SARS-CoV-2 entry
Published in Nature communications (21-11-2023)“…Since 2019, SARS-CoV-2 has evolved rapidly and gained resistance to multiple therapeutics targeting the virus. Development of host-directed antivirals offers…”
Get full text
Journal Article -
19
Oral remdesivir derivative VV116 is a potent inhibitor of respiratory syncytial virus with efficacy in mouse model
Published in Signal transduction and targeted therapy (16-04-2022)Get full text
Journal Article -
20
Research on optimal allocation of flow and head in cascade pumping stations based on Harris hawks optimization
Published in Water science & technology. Water supply (01-01-2024)“…Abstract To address the problems of massive energy consumption and low operating efficiency in cascade pumping stations (CPSs), an optimized scheduling model…”
Get full text
Journal Article